Stocksigma LogoStocksigma Logo

Infinium Pharmachem Reports Strong H1 FY27 Performance

Infinium Pharmachem reported a 54.3% YoY rise in consolidated revenue from operations to ₹129.72 cr for the half year ended 30th Sep'26, compared to ₹84.05

Infinium Pharmachem Reports Strong H1 FY27 Performance

Infinium Pharmachem Ltd · Outcome · 06 Nov 2026, 6:53 pm

Infinium Pharmachem Reports Strong H1 FY27 Performance Infinium Pharmachem reported a 54.3% YoY rise in consolidated revenue from operations to ₹129.72 cr for the half year ended 30th Sep'26, compared to ₹84.05 cr in H1 FY26. Consolidated profit after tax attributable to owners grew 59.4% YoY to ₹8.93 cr from ₹5.60 cr, with diluted EPS improving to ₹5.73 from ₹3.59. On a standalone basis, revenue reached ₹112.01 cr, up 54.3% YoY, while net profit rose 58.2% YoY to ₹7.34 cr. Operating cash flow strengthened significantly to ₹7.40 cr.

Original exchange filing (PDF)

More announcements from Infinium Pharmachem Ltd

All Infinium Pharmachem Ltd announcements